Cigarette Smoking Clinical Trial
Official title:
Primary Care-based Patient Navigation to Promote Smoking Cessation Treatment: a Pilot Randomized Controlled Trial
Verified date | January 2016 |
Source | Boston University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Cigarette smoking is a highly significant health threat, responsible for more than 430,000
deaths each year. Low-income persons and racial/ethnic minorities are at particularly high
risk, smoking at greater rates and having greater tobacco-related morbidity and mortality
than other persons. Yet poor and minority smokers are less likely to receive advice to stop
smoking or to use tobacco cessation services. Using non-physician members of the health care
team as patient navigators to connect low-income and minority smokers to evidence-based
tobacco treatment services is a promising approach because 1) many primary care providers
(PCPs) are unable to provide counseling to patients who smoke due to time constraints; 2)
minority patients may be less aware of smoking cessation resources and may have
misconceptions about tobacco dependence treatments; and 3) as primary care practices are
redesigned as medical homes, non-physician members of the health care team will increasingly
be taking on tasks previously performed by PCPs. Patient navigators are lay persons from the
community, working as paid employees, who are trained to guide patients through the health
care system to receive services. Information on the efficacy of patient navigation to
connect vulnerable patients to smoking cessation services is needed.
The investigators will implement a patient navigation-based intervention in the primary care
setting to promote engagement of low-income and minority patients in smoking cessation
treatment. To test our intervention, the investigators will conduct a pilot randomized
control trial (RCT), randomizing 240 patients to the intervention condition (patient
navigation) or an enhanced traditional care (ETC) control condition. The investigators will
perform follow-up at three months following the start of the intervention, with a primary
outcome of engagement in smoking cessation treatment.
Status | Completed |
Enrollment | 47 |
Est. completion date | December 2012 |
Est. primary completion date | December 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. age > 18 years 2. smoked cigarettes in the past week 3. have a scheduled visit with a PCP 4. telephone access 5. English speaking 6. able and willing to participate in the study protocol and provide informed consent. Exclusion Criteria: 1. planning to move out of the area within the next 6 months 2. cognitive impairments that preclude participation in study activities. 3. severe illness or distress 4. inability to read/understand English 5. actively using evidence-based smoking cessation treatment, and 6. transient residence or lack of a telephone for follow-up assessments. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Boston University | National Center for Research Resources (NCRR) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | engagement in smoking cessation treatment | This is a dichotomous variable, Y/N, based on a) completion of > 1 quit line counseling session (based on self-report) OR b) > 1 PCP visit in which smoking cessation treatment is discussed (patient self-report and medical record review of progress notes) OR c) Completion of > 1 session of a BMC smoking cessation group (medical record review). | 3 months | No |
Secondary | Stage of change with regard to smoking cessation | Stage of change is assessed at baseline and 3 months, according to the following categories: pre-contemplation, contemplation, preparation, or action. For each participant, we compare stage of change at baseline vs. 3 months. | 3 months | No |
Secondary | Use of tobacco treatment medications | self-reported use of prescribed and OTC medications. | 3 months | No |
Secondary | level of nicotine dependence | Fagerstrom Test for Nicotine Dependence | 3 months | No |
Secondary | use of other tobacco treatment support | self-report of all tobacco treatment support received, including support from non-study sources, including the internet, during the study period. | 3 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Active, not recruiting |
NCT02643914 -
Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings
|
N/A | |
Recruiting |
NCT02422914 -
Benefits of Tobacco Free Cigarette
|
N/A | |
Active, not recruiting |
NCT02629679 -
Sports, Education and Consumption of Substances in Adolescents
|
N/A | |
Completed |
NCT02385227 -
Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes
|
N/A | |
Completed |
NCT02218281 -
Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation
|
N/A | |
Completed |
NCT01199380 -
Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms
|
Phase 2 | |
Completed |
NCT01081119 -
Brief Voluntary Alcohol and Drug Intervention for Middle School Youth
|
Phase 2 | |
Completed |
NCT01692353 -
Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers
|
N/A | |
Completed |
NCT00756704 -
The Effectiveness of Smoking Cessation Guidelines in the Emergency Department
|
N/A | |
Completed |
NCT00802919 -
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
|
Phase 4 | |
Completed |
NCT00682474 -
School Nurse-Delivered Smoking Cessation Intervention
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05520775 -
Semaglutide for Alcohol Use Disorder
|
Phase 2 | |
Terminated |
NCT03840694 -
Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior
|
N/A | |
Not yet recruiting |
NCT06032793 -
Effects of Deep Breathing Exercise on Pulmonary Function, Perceived Stress and Physical Fitness.
|
N/A | |
Terminated |
NCT03326128 -
High Dose Bupropion for Smoking Cessation - Pilot Study
|
Phase 2 | |
Recruiting |
NCT03218670 -
Your Health in On Click
|
N/A | |
Completed |
NCT02538042 -
Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)
|
N/A | |
Completed |
NCT02792426 -
Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users
|
Phase 1 |